Hepatitis B gene therapies - Huidagene Therapeutics
Alternative Names: HBV-Huidagene TherapeuticsLatest Information Update: 22 Sep 2023
At a glance
- Originator HuidaGene Therapeutics
- Class Antivirals; Gene therapies
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Hepatitis B
Most Recent Events
- 12 Sep 2023 Early research in Hepatitis B in China, prior to September 2023 (Parenteral) (HuidaGene Therapeutics pipeline, September 2023)